PortfoliosLab logoPortfoliosLab logo
CGVV vs. CDC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CGVV vs. CDC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Capital Group U.S. Large Value ETF (CGVV) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CGVV achieves a 14.38% return, which is significantly lower than CDC's 16.64% return.


CGVV

1D
-0.16%
1M
0.62%
6M
10.00%
YTD
14.38%
1Y
19.83%
3Y*
5Y*
10Y*

CDC

1D
-0.71%
1M
1.84%
6M
14.07%
YTD
16.64%
1Y
20.44%
3Y*
13.47%
5Y*
6.76%
10Y*
10.20%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CGVV vs. CDC - Yearly Performance Comparison


Correlation

The correlation between CGVV and CDC is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.51

Correlation (All Time)
Calculated using the full available price history since Jun 26, 2025

0.51

The correlation between CGVV and CDC has been stable across timeframes, ranging from 0.51 to 0.51 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CGVV vs. CDC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CGVV
CGVV Risk / Return Rank: 5151
Overall Rank
CGVV Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
CGVV Sortino Ratio Rank: 5252
Sortino Ratio Rank
CGVV Omega Ratio Rank: 4848
Omega Ratio Rank
CGVV Calmar Ratio Rank: 4949
Calmar Ratio Rank
CGVV Martin Ratio Rank: 5656
Martin Ratio Rank

CDC
CDC Risk / Return Rank: 8080
Overall Rank
CDC Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
CDC Sortino Ratio Rank: 8383
Sortino Ratio Rank
CDC Omega Ratio Rank: 7373
Omega Ratio Rank
CDC Calmar Ratio Rank: 8484
Calmar Ratio Rank
CDC Martin Ratio Rank: 8282
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CGVV vs. CDC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Capital Group U.S. Large Value ETF (CGVV) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CGVVCDCDifference
Sharpe ratioReturn per unit of total volatility

-0.59

Sortino ratioReturn per unit of downside risk

-0.90

Omega ratioGain probability vs. loss probability

1.25

1.34

-0.09

Calmar ratioReturn relative to maximum drawdown

1.97

3.62

-1.65

Martin ratioReturn relative to average drawdown

7.69

12.75

-5.06

CGVV vs. CDC - Sharpe Ratio Comparison

The current CGVV Sharpe Ratio is 1.43, which is comparable to the CDC Sharpe Ratio of 2.02. The chart below compares the historical Sharpe Ratios of CGVV and CDC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CGVV vs. CDC - Drawdown Comparison

The maximum CGVV drawdown since its inception was -10.11%, smaller than the maximum CDC drawdown of -21.37%. Use the drawdown chart below to compare losses from any high point for CGVV and CDC.


Loading charts...

Drawdown Indicators


CGVVCDCDifference

Max Drawdown

Largest peak-to-trough decline

-10.11%

-21.37%

+11.26%

Max Drawdown (1Y)

Largest decline over 1 year

-10.11%

-5.67%

-4.44%

Max Drawdown (3Y)

Largest decline over 3 years

-12.70%

Max Drawdown (5Y)

Largest decline over 5 years

-21.37%

Max Drawdown (10Y)

Largest decline over 10 years

-21.37%

Current Drawdown

Current decline from peak

-0.78%

-0.82%

+0.04%

Average Drawdown

Average peak-to-trough decline

-1.56%

-5.07%

+3.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.59%

1.61%

+0.98%

Volatility

CGVV vs. CDC - Volatility Comparison

Capital Group U.S. Large Value ETF (CGVV) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) have volatilities of 3.78% and 3.93%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CGVVCDCDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.78%

3.93%

-0.15%

Volatility (6M)

Calculated over the trailing 6-month period

10.65%

7.43%

+3.22%

Volatility (1Y)

Calculated over the trailing 1-year period

13.90%

10.16%

+3.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

13.72%

12.54%

+1.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

13.72%

13.19%

+0.53%

CGVV vs. CDC - Expense Ratio Comparison

CGVV has a 0.33% expense ratio, which is lower than CDC's 0.37% expense ratio.


Dividends

CGVV vs. CDC - Dividend Comparison

CGVV's dividend yield for the trailing twelve months is around 0.85%, less than CDC's 3.08% yield.


PositionTTM20252024202320222021202020192018201720162015
CDC
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
3.08%3.36%3.32%4.24%3.48%2.65%2.48%3.04%3.37%2.81%2.99%3.17%
CGVV
Capital Group U.S. Large Value ETF
0.85%0.57%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


CGVV and CDC have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CDC has higher volatility (3.93%) compared to CGVV (3.78%). In terms of maximum drawdown, CGVV dropped -10.11% vs CDC's -21.37%.

On 1-year performance, CDC leads with 20.44% vs 19.83% for CGVV. On fees, CGVV is cheaper at 0.33% per year. On volatility, CGVV has been the lower-risk option at 3.78%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, CDC has performed better with a 20.44% return vs 19.83%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CGVV is cheaper with a 0.33% expense ratio, compared with 0.37% for CDC.

CDC has the higher dividend yield at 3.08%, compared with 0.85% for CGVV.

They also come from different issuers: Capital Group and Crestview. Their fees differ too: 0.33% for CGVV and 0.37% for CDC.

CDC currently has the higher Sharpe Ratio (2.02 vs 1.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CGVV and CDC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer